Trial intelligence / Profile preview

Fimasartan in Aortic Stenosis

NCT01589380Phase 4Unknown

Sponsor
Seoul National University Hospital
Start
Apr 2012
Primary completion
May 2013
Modality
Small Molecules
Countries
1
01

Overview

Phase 4, randomised, double-blind trial in aortic stenosis (AS) comparing Placebo Arm with Fimasartan (2 arms). Primary endpoint: Change of VmaxO2 in Cardiopulmonary Exercise Test at 1 year. Status: unknown.

02

Drugs

fimasartan
03

Conditions

aortic stenosis (AS)

Beyond the preview

Go deeper on NCT01589380.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT01589380.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call